Haleon demerger shows spin-offs don’t protect from terrible markets
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings
EquityEquity IPOs

Haleon demerger shows spin-offs don’t protect from terrible markets

Victoria Thiele
July 18, 2022 05:49 PM
The American pharmaceutical company Pfizer has decided to sell its share in the consumer health care company Haleon, which is co-owned with the British GSK, in connection with a stock exchange listing planned for 18 July. Haleon owns brands such as the pa

GSK’s consumer health business trades down on London debut

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOsBank of AmericaCitiGoldman SachsUKHealth and Biotech
VT
Victoria Thiele
Senior Reporter - CLOs
Contact
Gift this article